NAD Research, Inc., a Louisiana 501(c)(3) nonprofit organization, is to investigate the therapeutic applications of intravenous Nicotinamide Adenine Dinucleotide (NAD+). With our educational division, we can translate our clinical findings through physician education for improved patient outcomes and set standards for the industry.
